News
Mr. Andrew Lin’s appointment as Chairman of TaiRx, Inc. is effective as of December 9, 2020.
2020/12/9 Andrew Lin [...]
TaiRx’s anti-cancer drug CVM-1118 won the renewal of Excelsior Award in 2020.
2020/12/1 Having been [...]
TaiRx successfully raised 504 million NTD in capital.
2020/11/27 To enrich [...]
TaiRx ranked first in Taiwan for the most innovative pharmaceutical companies in the APAC region
2019/8/30 World-renowned professional [...]